Junya Azuma

[Gene therapy for myocardial regeneration].

Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor.

Therapeutic angiogenesis using hepatocyte growth factor (HGF).

Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease.

[Gene therapy for diabetic microangiopathy].

[Therapeutic angiogenesis for ischemic heart disease induced by gene transfer].

[Gene therapy in congestive heart failure].

Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin.

Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence.

Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells.

Apelin is necessary for the maintenance of insulin sensitivity.

Modern role for clopidogrel in management of atrial fibrillation and stroke reduction.

New options with dabigatran etexilate in anticoagulant therapy.

Hyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.

Hepatocyte growth factor attenuates renal fibrosis through TGF-β1 suppression by apoptosis of myofibroblasts.

MicroRNA-26a is a novel regulator of vascular smooth muscle cell function.

Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.

Influences of aortic motion and curvature on vessel expansion in murine experimental aneurysms.

Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia.

Assessment of elastase-induced murine abdominal aortic aneurysms: comparison of ultrasound imaging with in situ video microscopy.

Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway.

Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm.

Maternal heme oxygenase 1 regulates placental vasculature development via angiogenic factors in mice.

Selective Glucocorticoid Receptor (GR-II) Antagonist Reduces Body Weight Gain in Mice.

Plasmid DNA-based gene transfer with ultrasound and microbubbles.

Three-dimensional microstructural changes in murine abdominal aortic aneurysms quantified using immunofluorescent array tomography.

Role of serotonin in angiogenesis: Induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice.

Telmisartan Exerts Renoprotective Actions via Peroxisome Proliferator-Activated Receptor-γ/Hepatocyte Growth Factor Pathway Independent of Angiotensin II Type 1 Receptor Blockade.

Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development.